The Chinese Beijing Genomics Institute (BGI) is one of the largest companies in the medical research area. BGI was founded in 1999 in Shenzhen, Guangdong, as a genetic research centre, specialized in genome sequencing. From its inception until now, the company has transformed from a research institute that decoded the DNA of pandas and rice into a company active in animal cloning and health testing. Also read: No social-democrats in power, no success for China BGI’s breakthrough occurred at the beginning of 2020, when it announced that it would make genome decoding cheaper and would be capable of decoding the genomes
Ultima oră